Thrombotic complications of central venous catheters in cancer patients

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue 2, 1999, Pages 147-155

  Bona, Robert D ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Anticoagulants; Cancer; Catheter; Fibrinolysis; Thrombosis

Indexed keywords

DALTEPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

ANTICOAGULANT THERAPY; CANCER PATIENT; CENTRAL VENOUS CATHETER; COLOR ULTRASOUND FLOWMETRY; DIAGNOSTIC APPROACH ROUTE; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOGENESIS; THROMBOSIS; THROMBOSIS PREVENTION;

EID: 0032964291     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994916     Document Type: Review

References (73)

1. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973;36:602-606
2. Hickman RO, Buckner CD, Clift RA, et al. A modified right atrial catheter for access to the venous system in marrow transplant recipient. Surg Gynecol Obstet 1979;148:871-875
3. Niederhuber JE, Ensminger WD, Gyves JW, et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982;92:706-712
4. Crowley JJ, Pereira JK, Harris LS, Becker CJ. Peripherally inserted central catheters: Experience in 523 Children. Radiology 1997;204:617-621
5. Moore C, Heffernan I, Sheldon S. Diagnosis and management of subclavian vein thrombosis. J Infusional Chemotherapy 1992;2:151-152
6. Davis CL. Upper extremity venous thrombosis and central venous catheters. Crit Care Nurse 1991;11:16-22
7. Lamberth WC, Wright CB. Deep venous thrombosis of the upper extremity. In: Collins GJ, ed. Vascular and Occlusive Disorders: Medical and Surgical Management. Mt. Kisco, NY: Futura Publishing; 1981:71-90
8. Ledgerwood AM, Saxe JM, Lucas CE. Venous access devices: A review. Surg Annu 1993;25:45-57
9. Complications associated with the use of central venous access devices. Curr Probl Surg 1996;33:311-377
10. Weschsler RJ, Spirn PW, Conant EF, Steiner RM, Needleman L. Thrombosis and infection caused hy thoracic venous catheters: Pathogenesis and imaging findings. Am J Radiol 1993;160: 467-471
11. Anderson AJ, Krasnow SH, Boyer MW, et al. Thrombosis: The major Hickman catheter complication in patients with solid tumor. Chest 1989;95:71-75
12. Horne MK, May DJ, Alexander R, et al. Venographic surveillance of tunneled venous access devices in adult oncology patients. Ann Surg Oncol 1995;2:174-178
13. Balestreri L, De Cicco M, Matovic M, Coran F, Morassut S. Central venous catheter-related thrombosis in clinically asymptomatic oncologic patients: A phlebographic study. Eur J Radiol 1995;20:108-111
14. Mueller BU, Skelton J, Callender DPE, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992;10:1943-1948
15. Gould JR, Carloss HW, Skinner WL. Groshong catheter-associated subclavian venous thrombosis. Am J Med 1993;95:419-423
16. Torramade JR, Cienfuegos JA, Hernandez JL, et al. The complications of central venous access systems: A study of 218 patients. Eur J Surg 1993;159:323-327
17. Schwarz RE, Groeger JS, Coit DG. Subcutaneously implanted central venous access devices in cancer patients. Cancer 1997;79:1635-1640
18. Loughran SC, Borzatta M. Peripherally inserted central catheters: A report of 2506 catheter days. J Parenteral Enteral Nutrition 1995;19:133-136
19. Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access systems: Experience in 1500 patients with totally implanted central venous port systems. World J Surg 1998;22:12-16
20. Nightingale CE, Norman A, Cunningham D, et al. A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy. Eur J Cancer 1997;33:398-403
21. Moss JF, Wagman LD, Riihimaki DU, Terz JJ. Central venous thrombosis related to the silastic Hickman-Broviac catheter in an oncologic population. J Parenteral Enteral Nutrition 1989; 13:397-400
22. Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995;13:233-238
23. Freytes C, Reid P, Smith KL. Long term experience with a totally implantable catheter system in cancer patients. J Surg Oncol 1990;45:99-102
24. Lokich JL, Becker B. Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy. Cancer 1983;52:1586-1589
25. Haire WD, Lieberman RP, Lund GB, et al. Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: Prospective comparison of Hickman and Groshong catheters. Bone Marrow Transplant 1991;7:57-59
26. Puel V, Cuadry M, LeMetayer P, et al. Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer 1993;72:2248-2252
27. Haire WD, Lieberman RP, Edney J, et al. Hickman catheter-induced thoracic vein thrombosis. Cancer 1990;66:900-908
28. Conlan MG, Haire WD, Lieberman RP, et al. Catheter related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation. Bone Marrow Transplant 1991;7:235-240
29. Sletnes KE, Holte H, Halvorsen S, et al. Activation of coagulation and deep vein thrombosis after bone marrow harvesting and insertion of a Hickman-catheter in ABMT patients with malignant lymphoma. Bone Marrow Transplant 1996;17:577-581
30. Stephens LC, Haire WD, Schmit-Pokorny K, Kessinger A, Kotulak G. Granulocyte macrophage colony stimulating factor: High incidence of apheresis catheter thrombosis during peripheral stem cell collection. Bone Marrow Transplant 1993;11:51-54
31. Eastman M, Khorsand M, Maki D, et al. Catheter-related bacteremia and thrombosis in patients treated with moderate dose, continuous infusion interleukin-2. Proc Am Soc Clin Oncol 1998;17:437a (Abst)
32. Strinden WD, Helgerson RB, Maki DG. Candida septic thrombosis of the great central veins associated with central catheters. Ann Surg 1985;202:653-658
33. Ratcliffe FM. Suppurative thrombosis of the superior vena cava: A lethal complication of central venous catheters. Intensive Care Med 1985;11:265-266
34. Stillman RM, Soliman F, Carcia L, et al. Etiology of catheter associated sepsis. Correlation with thrombogenicity. Arch Surg 1977;112:1497-1499
35. 35. Ashkenazi S, Mirelman D. Adherence of bacteria to pediatric intravenous catheters and needles and its relation to phlebitis in animals. Pediatr Res 1984;18:1361-1366
36. Hawiger J, Hammon DK, Timmons S, et al. Interaction of human fibrinogen with staphylococci: Presence of a binding region on normal and abnormal fibrinogen variants and fibrinogen derivatives. Blood 1978;51:799-812
37. Kuusela P. Fibronectin binds to Staphylococcus aureus. Nature 1978;276:718-720
38. Vaudaux P, Pittet D, Haeberli A, et al. Host factors selectively increase staphylococcal adherence on inserted catheters: A role for fibronectin and fibrinogen or fibrin. J Infect Dis 1989;160:865-875
39. Hermann M, Vaudaux P, Pittet D, et al. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988;158: 693-700
40. Raad I, Luna M, Khalil SM, et al. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994;271:1014-1016
41. Horattas MC, Wright DJ, Fenton AH, et al. Changing concepts of deep venous thrombosis of the upper extremity - Report of a series and review of the literature. Surgery 1988;104:561-567
42. Donayre CE, White GH, Mehringer SM, Wilson SE. Pathogenesis determines late morbidity of axillosubclavian vein thrombosis. Am J Surg 1986;152:179-184
43. Black MD, French GJ, Rasuli P, Couchard AC. Upper extremity deep venous thrombosis. Chest 1993;103:1887-1890
44. Harley DP, White RA, Nelson RJ, Mehringer CM. Pulmonary embolism secondary to venous thrombosis of the arm. Am J Surg 1984;147:221-224
45. Monreal M, Lafoz E, Ruiz J, Valls R, Alastrue A. Upper extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest 1991;99:280-283
46. Becker DM, Philbrick JT, Walker FB. Axillary and subclavian venous thrombosis. Arch Intern Med 1991;151:1934-1943
47. Prandoni P, Polistena P, Bernardi E, et al. Upper extremity deep vein thrombosis. Risk factors, diagnosis and complications. Arch Intern Med 1997;157:57-62
48. Monreal M, Raventos A, Lerma R, et al. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines - A prospective study. Thromb Haemost 1994;72:548-550
49. Leiby JM, Purcell H, DeMaria JJ, et al. Pulmonary embolism as a result of Hickman catheter related thrombosis. Am J Med 1989;86:228-231
50. Horne MK, Mayo DJ, Alexander HR, et al. Upper extremity impedance plethysmography in patients with venous access de vices. Thromb Haemost 1994;72:540-542
51. Longley DG, Finlay DE, Letoumeau JG. Sonography of the upper extremity and jugular veins. Am J Radiol 1993;160:957-962
52. Haire, WD, Lynch TG, Lieberman RP, Lund GH, Edney JA. Utility of duplex ultrasound in the diagnosis of asymptomatic catheter-induced subclavian vein thrombosis. J Ultrasound Med 1991;10:493-496
53. Koskoy C, Kuzu A, Kutlay J, et al. The diagnostic value of colour Doppler ultrasound in central venous catheter related thrombosis. Clin Radiol 1995;50:687-689
54. Grassi CJ, Polak JF. Axillary and subclavian venous thrombosis: Follow-up evaluation with color Doppler flow US and venography. Radiology 1990;175:651-654
55. Hubsch PJS, Stiglbauer RL, Schwaighofer BWAM, Kainberger FM, Barton PPA. Internal jugular and subclavian vein thrombosis caused by central venous catheters. Evaluation using Doppler blood flow imaging. J Ultrasound Med 1988;7:629-636
56. Williams N, Bradley A, Mamtora H, et al. A prospective evaluation of central venous blood flow using Doppler ultrasound in patients with a long term venous catheter. Eur J Clin Nutrition 1997;51:123-124
57. Wells PS, Lensing AWA, Davidson BL, Prins MH, Hirsh J. Accuracy of ultrasound for the diagnosis of deep vein thrombosis in asymptomatic patients after orthopedic surgery. Ann Intern Med 1995;122:47-53
58. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990;112:423-428
59. Upper extremity deep venous thrombosis in cancer patients with venous access devices - prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996;75:21-23
60. Cassidy FP, Zajko AB, Bron KM, et al. Noninfectious compliations of long term central venous catheters: Radiologic evaluation and management. Am J Radiol 1987;149:671-675
61. Wachs T. Urokinase administration in pediatric patients with occluded central venous catheters. J Intravenous Nursing 1990; 13:100-102
62. Monturo CA, Dickerson RN, Mullen JL. Efficacy of thrombolytic therapy for occlusion of long-term catheters. J Parent Enteral Nutrition 1990;14:312-314
63. Haire WD, Atkinson JB, Stephens LC, Kotulak GD. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: A double-blinded, randomized trial. Thromb Haemost 1994;72:543-547
64. Haire WD, Lieberman RP, Lund GB, Edney J, Wieczorek BM. Obstructed central venous catheters. Restoring function with a 12 hour infusion of low dose urokinase. Cancer 1990;66: 2279-2285
65. Haire WD, Lieberman RP. Thrombosed central venous catheters: Restoring function with 6-hour urokinase infusion after failure of bolus urokinase. J Parent Enteral Nutrition 1992;16:129-132
66. Fankuchen EI, Neff RA, Collins RA, Todd GJ, Martin EC. Urokinase perfusion for axillary-subclavian vein thrombosis. Cardiovasc Intervent Radiol 1984;7:90-93
67. Becker GJ, Holden RW, Rabe , et al. Local thrombolytic therapy for subclavian and axillary vein thrombosis. Radiology 1983;149:419-423
68. Druy EM, Trout HH, Giordano JM, Hix WR. Lytic therapy in the treatment of axillary and subclavian vein thrombosis. J Vasc Surg 1985;2:821-827
69. Fraschini G, Jadeja J, Lawson M, et al. Local infusion of urokiase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients. J Clin Oncol 1987;5: 672-678
70. Gray BH, Olin JW, Graor RA, et al. Safety and efficacy of thrombolytic therapy for superior vena cava syndrome. Chest 1991;99:54-59
71. Rodenhuis S, van't Hek LGFM, Vlasveld T, et al. Central venous catheter associated thrombosis of major veins: Thrombolytic treatment with recombinant tissue plasminogen activator. Thorax 1993;48:559-559
72. Schindler J, Bona RD, Chen HH, et al. Regional thrombolysis with urokinase for central venous catheter related thrombosis in patients undergoing high dose chemotherapy with autologous blood stem cell rescue. Clin Appl Thromb Hemost, in press
73. Smith VC, Hallett JW. Subclavian vein thrombosis during prolonged catheterization for purenteral nutrition: Early management and long term follow up. Southern Med J 1983;76:603-606